Enanta Pharmaceuticals Inc (ENTA) Insider Trading
- $2,977,699.00
- $79,432,036.39
- July 15, 2024
- Paul J Mellett
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 15, 2024 | Insider | 5,375 | $17.08 | Sell | $91,805.00 | |
July 11, 2024 | Insider | 4,299 | $15.07 | Sell | $64,785.93 | |
June 17, 2024 | Insider | 7,266 | $12.33 | Sell | $89,589.78 | |
Dec. 13, 2023 | Director | 15,295 | $9.12 | Sell | $139,490.40 | |
Dec. 5, 2023 | CMO | 534 | $9.63 | Sell | $5,142.42 | |
Dec. 5, 2023 | CFO | 2,412 | $9.63 | Sell | $23,227.56 | |
Dec. 5, 2023 | CEO | 7,230 | $9.63 | Sell | $69,624.90 | |
Dec. 5, 2023 | VP | 2,125 | $9.63 | Sell | $20,463.75 | |
March 15, 2023 | CFO | 10,440 | $44.43 | Sell | $463,849.20 | |
March 15, 2023 | VP | 13,925 | $44.45 | Sell | $618,966.25 | |
March 13, 2023 | CEO | 27,912 | $45.16 | Sell | $1,260,505.92 | |
Feb. 9, 2023 | CFO | 5,000 | $53.76 | Sell | $268,800.00 | |
Dec. 16, 2022 | CEO | 30,000 | $44.72 | Sell | $1,341,600.00 | |
April 4, 2022 | VP | 32,785 | $72.18 | Sell | $2,366,421.30 | |
April 1, 2022 | VP | 50,559 | $71.23 | Sell | $3,601,317.57 | |
March 21, 2022 | Director | 6,000 | $67.83 | Sell | $406,980.00 | |
March 1, 2022 | VP | 24,339 | $70.26 | Sell | $1,710,058.14 | |
Jan. 11, 2022 | VP | 12,536 | $70.13 | Sell | $879,149.68 | |
Dec. 1, 2021 | VP | 13,523 | $86.35 | Sell | $1,167,711.05 | |
Nov. 1, 2021 | VP | 9,547 | $84.89 | Sell | $810,444.83 | |
Oct. 11, 2021 | VP | 4,047 | $70.34 | Sell | $284,665.98 | |
Oct. 8, 2021 | VP | 13,453 | $70.09 | Sell | $942,920.77 | |
Sept. 15, 2021 | CEO | 4,516 | $59.06 | Sell | $266,714.96 | |
Jan. 8, 2021 | CFO | 6,000 | $45.58 | Sell | $273,480.00 | |
Jan. 2, 2020 | CFO | 10,000 | $60.88 | Sell | $608,800.00 | |
March 11, 2019 | Director | 1,546 | $99.16 | Sell | $153,301.36 | |
March 4, 2019 | Director | 9,280 | $103.65 | Sell | $961,872.00 | |
March 1, 2019 | VP | 10,000 | $103.53 | Sell | $1,035,300.00 | |
Feb. 13, 2019 | VP | 3,270 | $95.28 | Sell | $311,565.60 | |
Feb. 12, 2019 | Director | 7,734 | $90.01 | Sell | $696,137.34 | |
Feb. 11, 2019 | VP | 27,684 | $89.39 | Sell | $2,474,672.76 | |
Oct. 1, 2018 | Insider | 25,000 | $83.64 | Sell | $2,091,000.00 | |
Sept. 20, 2018 | VP | 4,155 | $95.32 | Sell | $396,054.60 | |
Aug. 20, 2018 | VP | 4,155 | $92.32 | Sell | $383,589.60 | |
July 18, 2018 | VP | 5,045 | $124.84 | Sell | $629,817.80 | |
July 6, 2018 | Insider | 35,000 | $125.24 | Sell | $4,383,400.00 | |
June 18, 2018 | VP | 4,155 | $114.85 | Sell | $477,201.75 | |
June 11, 2018 | Treasurer | 15,000 | $120.57 | Sell | $1,808,550.00 | |
May 17, 2018 | Insider | 25,000 | $105.83 | Sell | $2,645,750.00 | |
May 16, 2018 | VP | 4,155 | $105.25 | Sell | $437,313.75 | |
April 16, 2018 | VP | 4,225 | $85.58 | Sell | $361,575.50 | |
March 19, 2018 | Treasurer | 9,000 | $86.48 | Sell | $778,320.00 | |
Jan. 4, 2017 | Insider | 13,921 | $35.09 | Sell | $488,487.89 | |
Nov. 29, 2016 | Insider | 13,921 | $31.44 | Sell | $437,676.24 | |
May 11, 2016 | VP | 500 | $24.45 | Buy | $12,225.00 | |
Feb. 12, 2016 | Director | 2,000 | $27.04 | Buy | $54,080.00 | |
Nov. 24, 2015 | CFO | 6,000 | $30.15 | Sell | $180,900.00 | |
Oct. 15, 2015 | CFO | 7,500 | $40.10 | Sell | $300,750.00 | |
Sept. 8, 2015 | CFO | 7,500 | $39.55 | Sell | $296,625.00 | |
July 13, 2015 | CFO | 7,500 | $46.29 | Sell | $347,175.00 |
Insiders are both buying and selling Enanta Pharmaceuticals Inc stock.
The insider traders at Enanta Pharmaceuticals Inc are: Nathalie Adda, Paul J Mellett, Yat Sun Or, Jay R Luly, Saints Capital Granite, L.P., Paul J. Mellett, V Life Science Ventures Gm Tvm, Scott T Rottinghaus, Nathaniel S Gardiner, Bruce L A Carter, Jay Luly, Stephen Jr. Buckley, Terry Vance, Brendan Luu, Tara Lynn Kieffer, Helmut Schuhsler, Tim Ocain, George Golumbeski, and Marc E Goldberg
The most active insider trader at Enanta Pharmaceuticals Inc is Nathalie Adda with 14 trades.
V Life Science Ventures Gm Tvm has sold the most Enanta Pharmaceuticals Inc stock with a total value of $45,514,905.15.
Helmut Schuhsler has bought the most Enanta Pharmaceuticals Inc stock with a total value of $3,722,572.00.
The most recent insider trade for Enanta Pharmaceuticals Inc was on July 15, 2024.
The single biggest insider buy for Enanta Pharmaceuticals Inc was from Helmut Schuhsler with a total value of $1,861,286.00 on March 26, 2013.
The single biggest insider sell for Enanta Pharmaceuticals Inc was from V Life Science Ventures Gm Tvm with a total value of $17,054,945.88 on March 4, 2014.